Effect of topical and oral Resveratrol on skin health, condition and visible signs of ageing, in healthy ageing females.

Phase 3

Completed

• Conditions: Skin health; Visible signs of skin ageing; Skin - Normal skin development and function; Skin condition - pores, sebum, wrinkle, pigment condition, moisture, elasticity, skin toneand skin temperature; Skin condition - pores, sebum, wrinkle, pigment condition, moisture, elasticity, skin tone; and skin temperature

• Registration Number: ACTRN12621000709842
• Lead Sponsor: RDC Clinical Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-08
• Study Completion: 2022-11-29
• Last Update Posted: 2023-03-27

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 136

Inclusion Criteria

•Females aged 40 years and above
•Otherwise healthy
•Agree not to change standard skincare routine
•Able to provide informed consent
•Agree not to undertake another clinical trial while enrolled in this trial

Exclusion Criteria

•Clinically significant medical conditions including, but not limited to, cardiovascular, neurological, psychiatric, renal, gastrointestinal, immunological, endocrine (including uncontrolled diabetes or thyroid disease) or haematological abnormalities that are uncontrolled
•Currently taking resveratrol or using resveratrol cream
•Cosmetic surgery and procedures, including Botox and other injectables, microdermabrasion, laser treatments
•Active smokers, nicotine use, alcohol or drug (prescription or illegal substances) abuse
•Chronic past and/or current alcohol use (Greater than 14 alcoholic drinks week)
•Known pregnant or lactating woman
•Allergies or hypersensitivity to resveratrol
•Any condition which in the opinion of the investigator makes the participant unsuitable for inclusion

Study & Design

• Study Type: Interventional
• Study Design: Not specified